On october 14-16, the international medical intellectual property organization (interpat) visited song jiang. Wang jian, deputy secretary-general of the district council of the songjiang region, and governor of the district, met with the delegation and held a meeting and exchange of views. Zhou hongwei, head of the songjiang region, participated。
The international medical intellectual property organization (interpat), a global non-profit organization based in basel, switzerland, is committed to promoting intellectual property protection in the field of medicine worldwide as a major driver of sustainable innovation for global health. As of june this year, the organization's membership includes over 30 globally recognized multinational drug companies, such as yoyo, johnson, abewi, senofi and merk。
On this visit, the members of the delegation visited matsu university to focus on innovations in scientific research. At the university of political science and law in east china, the delegation held an exchange with the head of the school on topics such as biomedicine intellectual property training. At the university of east china, the delegation then visited the showroom of material colleges, the joint laboratory of forensic health clinics at the college of crafts, etc., to learn more about the orientation of specialty studies, such as functional fibres and intelligent materials, to look closely at the results of research, such as acoustic fibres, and to interact with school representatives。
In addition, during the visit, the delegation visited governmental bodies such as the government of the songjiang region, the shanghai city council for science and technology and the shanghai city intellectual property authority and engaged in in-depth exchanges with relevant bodies such as the shanghai city arbitration commission, the shanghai international commercial conciliation court, the shanghai city advisory industry association and the shanghai intellectual property services association。
As the only think tank composed of chief intellectual property officers of leading global innovative multinational pharmaceutical companies, the international medical intellectual property organization contributes to the development of innovative ecosystems in the life sciences by strengthening respect for and protection of intellectual property rights by governments, industry and the public. During this visit to shanghai, members of the delegation indicated that the process of internationalization of the shanghai biomedicine industry was moving steadily from its previous “follow-up” model to a new phase of strategic transformation of “owned innovation, global output”. During the visit, members of the mission were greatly impressed by the innovative potential inherent in songjiang and by the wealth of research and development resources for production。
In the future, based on this visit, the organization will actively promote the establishment of china's representative offices in shanghai and the organization of professional international forums and exchanges of talent, while establishing close links with china's innovative pharmaceutical companies, government departments and regulatory agencies, and jointly promoting industrial innovation and global resource interface by promoting cooperation and exchanges between china's innovative pharmaceutical companies and the organization's members in order to inject new dynamics into the construction of an open and win-win industrial ecology。
